2024-02-22 10:35:19
The Director General of the National Social Security Fund, Muhammad Karki, announced the temporary payment of the Fund’s contribution to chronic disease medicines whose schedules are attached, as follows:
– 75% of the Fund’s contribution is for GENERIC medicines (set at 80%) according to the prices approved by the Ministry of Public Health.
– 35% of the Fund’s contribution is for BRAND medications (set at 80%) according to the prices approved by the Ministry of Public Health.
The amended drug lists subject to this percentage of the Fund’s contribution include regarding 630 medications that cover the treatment of the following chronic diseases: diabetes, high blood pressure, high blood cholesterol, medications to thin the blood, enlarged prostate, thyroid dysfunction, and gout.
In this context, the Director General called on the three production parties – the state, employers and workers – involved in financing the guarantee to cooperate and work seriously and immediately in order to secure the necessary additional financial resources, so that the guarantee can regain its pivotal role in maintaining health and social security in the country, through The true declaration of actual wages and all supplementary supplements to the salary by employers and through the state’s provision of exceptional social security assistance in accordance with Article 66 of its law and similar to what was provided to both the Ministry of Public Health and the State Employees Cooperative.
1708606039
#IMLebanon #Good #news #chronic #diseases
